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Abstract
Background: While the prevalence of type 2 diabetes mellitus (DM) is high, tailored risk scores
for screening among South Asian and African origin populations are lacking. The aim of this study
was, first, to compare the prevalence of (known and newly detected) DM among Hindustani
Surinamese, African Surinamese and ethnic Dutch (Dutch). Second, to develop a new risk score for
DM. Third, to evaluate the performance of the risk score and to compare it to criteria derived from
current guidelines.
Methods:  We conducted a cross-sectional population based study among 336 Hindustani
Surinamese, 593 African Surinamese and 486 Dutch, aged 35–60 years, in Amsterdam. Logistic
regressing analyses were used to derive a risk score based on non-invasively determined
characteristics. The diagnostic accuracy was assessed by the area under the Receiver-Operator
Characteristic curve (AUC).
Results: Hindustani Surinamese had the highest prevalence of DM, followed by African Surinamese
and Dutch: 16.7, 8.1, 4.2% (age 35–44) and 35.0, 19.0, 8.2% (age 45–60), respectively. The risk score
included ethnicity, body mass index, waist circumference, resting heart rate, first-degree relative
with DM, hypertension and history of cardiovascular disease. Selection based on age alone showed
the lowest AUC: between 0.57–0.62. The AUC of our score (0.74–0.80) was higher than that of
criteria from guidelines based solely on age and BMI and as high as criteria that required invasive
specimen collection.
Conclusion: In Hindustani Surinamese and African Surinamese populations, screening for DM
should not be limited to those over 45 years, as is advocated in several guidelines. If selective
screening is indicated, our ethnicity based risk score performs well as a screening test for DM
among these groups, particularly compared to the criteria based on age and/or body mass index
derived from current guidelines.
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Background
Type 2 diabetes mellitus (DM) is one of the most com-
mon chronic diseases the world over, and the number of
people with DM has risen sharply in recent years [1]. In
the United Kingdom (UK), DM affects almost 1.8 million
people, representing 3% of the population. There are also
up to a million people with undiagnosed (asymptomatic)
DM [2]. Other European countries report similarly high
figures [3]. Individuals with DM are at high risk for cardi-
ovascular disease (CVD). Adequate treatment of DM and
associated risk factors such as hypertension and dyslipi-
demia greatly reduces the risk of complications.
While it is argued that there is no justification for univer-
sal screening for diabetes, there is strong support for
screening and early treatment among population sub-
groups where DM is common and CVD risk is high [4].
Glucose levels are likely to be elevated for 10 years before
DM is diagnosed [5]. This has led to recommendations for
selective screening for DM by the American Diabetes Asso-
ciation (ADA) and Diabetes UK [6,7]. Current guidelines
include questionnaires based on risk factors (e.g. age ≥ 45
years, BMI > 25) or the use of more complex risk scores
which require invasive specimen collection [8-12].
These guidelines have been developed and tested particu-
larly among populations of white European origin. This
raises the question of whether they are valid for other eth-
nic groups as well, in particular populations of South
Asian and African origin in Europe. As the prevalence of
DM is higher in these groups, it may affect the efficiency
of screening. For instance, while type 2 DM in white Euro-
peans usually appears over the age of 40, it often appears
before the age of 40 among South Asians and African ori-
gin populations [2,13-16]. In addition, the association
between DM and its determinants might vary between
ethnic groups.
The limited evidence indeed indicates that a risk score for
DM developed for the white population is less efficient
among South Asians and Africans [17]. Because of this,
some guidelines recognize the necessity of adapting
screening programs to ethnicity. The ADA questionnaire
includes a question about ethnicity, and suggests screen-
ing before the age of 45 among specific groups [18]. How-
ever, to our knowledge, no tailored risk score for DM has
been developed specifically for populations of South
Asian or African origin. Moreover, it is not yet known at
what age screening for DM should start, and which selec-
tion criteria are most efficient for these ethnic groups.
Thus, the aim of our study was to provide information
needed to optimize screening criteria for DM among dif-
ferent ethnic groups, e.g. Hindustani and African Suri-
namese migrants. Given the similarities in geographic and
ethnic origin, it is expected that Hindustani Surinamese
have much in common with South Asian migrants, and
that African Surinamese are very similar to migrants of
Afro-Caribbean ancestry in the United Kingdom (UK).
First, we determined the prevalence of known and newly
detected DM in Hindustani Surinamese, African Suri-
namese, and ethnic Dutch (Dutch) in the Netherlands in
two age groups: 35 to 44 and 45 to 60 years. Second, we
developed a new risk score, based on ethnicity and bio-
medical risk factors that do not require invasive specimen
collection in clinical practice. Finally, we evaluated the
performance of that risk score and compared it with the
current criteria derived from guidelines.
Methods
The study population consisted of participants in the
SUNSET study (Surinamese in the Netherlands: Study on
health and Ethnicity) [19]. In 1975, almost half the pop-
ulation of the former Dutch colony Surinam migrated to
the Netherlands. Approximately 80% of these Surinamese
immigrants in the Netherlands are Hindustani ('South
Asian', originally from the Indian sub-continent) or Afri-
can (mixed African, Indian and European, but predomi-
nantly of African origin). The SUNSET study is based on a
random sample of 2975 individuals, aged 35 to 60 years
of age, drawn from the approximately 389000 ethnic
Dutch (Dutch) and 72000 Surinamese listed in the
Amsterdam population register (figure 1). For the sam-
pling procedure, persons who were born in the Nether-
lands and whose parents were both born in the
Netherlands were presumed to be Dutch. Persons of
whom both parents were born in Surinam and persons
who were born in Surinam and who had at least one par-
ent who was born in Surinam were presumed to be Suri-
namese participants.
Between 2001 and 2003, all persons in the sample were
approached for face-to-face, structured interviews by
trained interviewers who had been matched by sex and
presumed ethnicity. The interview included questions on
self-identified ethnicity, migration history, demographic
variables, lifestyle, and health status. If information on
the self-identified ethnicity of the individual was lacking,
the origin of the mother, the father and the mother's
ancestors were used to classify participants.
The overall response to the interview was 60% (figure 1).
Participation rates were higher among women than
among men. In addition, participants in the interview
were more likely to be married and living with a partner
and/or children, and to live in a less urban area (address
density of 1500–2500 addresses/km2 vs. ≥ 2500) as com-
pared to non-participants (both non-response and not eli-
gible). However, the absolute and relative differences
between participants and non-participants for these char-BMC Public Health 2008, 8:271 http://www.biomedcentral.com/1471-2458/8/271
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acteristics were small and reported trends were similar
across ethnic groups (data not shown).
Participants of Hindustani Surinamese, African Suri-
namese or Dutch origin were also invited for a physical
examination at a local health care centre. During the
examination, trained physicians recorded the following
characteristics: weight in light clothing on a SECA
mechanical scale to the nearest 200 grams and height to
the nearest 0.01 meter by wall tape measure. Waist cir-
cumference midway between the lower rib margin and the
iliac crest and hip circumference at the maximum point
over the greater trochanters were determined to the near-
est 0.01 meter by tape measure. After the subjects had
emptied their bladder and had been seated for at least 5
minutes, blood pressure and resting heart rate measure-
ments were obtained from each subject's arm at heart level
using an OMRON-M4 semi-automatic sphygmomanom-
eter with an appropriate-sized cuff. All anthropometric
measurements were obtained twice and the means
(rounded off to the nearest integer) were used for analysis.
Fasting glucose (HK/Glucose-6-P dehydrogenase test;
Roche Diagnostics, In), high density lipoprotein choles-
terol (HDL, Homogenous enzymatic colorimetric test;
Roche Diagnostics, In) and triglyceride (GPO-PAP Enzy-
matic test; Roche Diagnostics, In) levels were determined
in serum samples obtained at the time of the physical
examination. DM was defined as fasting glucose ≥ 7.0
mmol/l and/or self-reported DM, excluding the self-
reported diagnoses of gestational diabetes.
The SUNSET-study was approved by the Institutional
Review Board of the Academic Medical Centre of the Uni-
versity of Amsterdam, and carried out in compliance with
Flow chart of the inclusion into the study. Figure 1
Flow chart of the inclusion into the study. a Persons who had moved, were deceased or could not be reached at the reg-
istered address were not considered as potential participants. b Only persons of Hindustani Surinamese, African Surinamese or 
ethnic Dutch origin were invited for the physical examination (n = 1626). Javanese or Chinese Surinamese persons and persons 
with missing ethnicity were excluded (n = 71). c Persons without a fasting plasma sample (n = 10) or were excluded.BMC Public Health 2008, 8:271 http://www.biomedcentral.com/1471-2458/8/271
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the Helsinki Declaration. All participants provided a writ-
ten informed consent.
In the present analysis, we included participants who had
participated in both the interview and the physical exam-
ination. Of all participants in the interview, 71 were
excluded due to missing information on self-identified
ethnicity, 182 persons were excluded because they had
not undergone the physical exam and 10 persons because
fasting glucose measurements were not available (non-
response for blood sample). As compared to those who
were left in the study, those excluded were similar with
regard to gender, self-reported DM and self-rated health
(data not shown).
In total, 1434 participants remained in the study, divided
into 339 Hindustani Surinamese, 605 African Suri-
namese, and 490 Dutch (figure 1). Of the Hindustani par-
ticipants 98.8% were born in Surinam, 99.4 had two
parents who were born in Surinam and 92.1% had two
parents who were of Hindustani origin. Of the African
Surinamese participants, 99.2% were born in Surinam
and 99.5% had two parents who were born in Surinam.
Moreover, 79.3% of the African Surinamese had two par-
ents who were of African origin.
Characteristics of the ethnic groups were described using
means or proportions. In addition, the prevalence of
determinants of DM was calculated, directly standardised
to the age distribution of the total population. The associ-
ation of determinants with DM was studied using univar-
iate logistic regression analysis. All variables showing an
association of p ≤ 0.25 for the Wald test were selected for
the multivariate analyses. Stepwise multiple logistic
regression was then performed to construct the optimal
risk score for the occurrence of DM among Hindustani
Surinamese, African Surinamese and Dutch. Criteria for
entry into and exclusion from the model were a p-value
for the likelihood ratio test of 0.05 and 0.10, respectively.
A new risk score was developed to determine the probabil-
ity of having DM with a logistic regression model using
data that would be routinely available in general practice.
Variables considered were ethnicity, biomedical parame-
ters and disease history, e.g. age, BMI, waist circumfer-
ence, resting heart rate, first-degree relative with DM,
hypertension, history of CVD. The risk score is based on
the sum of the score of the variables included in the full
model (see additional file 1: Risk score for DM SUN-
SET.pdf).
Subsequently, we evaluated the performance of the risk
score and compared it to the sets of screening criteria
derived from current guidelines by calculating the area
under the Receiver-Operator Characteristic curve (AUC)
as a measure of diagnostic accuracy. Before analyzing the
data, it was decided to consider an AUC of less than 0.60
to be poor, 0.60–0.75 to be moderate, and higher than
0.75 to be good.
The cut-off for the risk scores at which fasting plasma glu-
cose screening was indicated, was chosen such that the
sensitivity was approximately 80%, but not over. Addi-
tionally, we determined the specificity, the total popula-
tion selected for screening, the prevalence in the screened
population (the positive predictive value), and the
number needed to screen to detect a case of DM (NNS).
Finally, we estimated the diagnostic accuracy of the risk
scores for the detection of a new case of DM, to simulate
a situation where persons with known DM are excluded
from screening. This was done because, ideally, only pre-
viously unknown cases would have been used in the deri-
vation of the risk score for screening for unknown DM.
However, given issues of power to enable statistical mod-
elling, it was decided to base the score on all cases and to
then also estimate the diagnostic accuracy of the risk
scores for newly detected DM.
We assessed the ability of a simplified version of our risk
score, with points corresponding to the calculated odds
ratio, to detect new cases of DM by calculating the number
needed to screen to identify a new case of newly detected
DM (NNSnew).
To assess the validity of the risk scores, we used bootstrap-
ping techniques to estimate a 'confidence interval' (bCI)
around the estimated AUC of all risk scores in our popu-
lation. We took 1000 random samples, with replacement,
from the study population. At each step the parameters in
the predictive models were calculated. We subsequently
estimated the AUC for each of the models and calculated
the 2.5 and 97.5th percentile to indicate the 'confidence
interval'[20].
All analyses were performed using the the SAS package,
version 9.1 (SAS Institute Inc., Cary, USA.).
Results
Characteristics of the population
Table 1 shows the characteristics of the study population
by ethnic group. Compared to the Dutch, the Surinamese
migrants tended to be congregated at the lower end of the
socio-economic structure. People of Hindustani Suri-
namese origin had more abdominal obesity than the Afri-
can Surinamese and Dutch.
Prevalence and determinants of DM
Overall, Hindustani Surinamese had the highest preva-
lence of DM 25.6%, followed by African Surinamese
12.7% and Dutch 6.8%. The age-standardised prevalenceBMC Public Health 2008, 8:271 http://www.biomedcentral.com/1471-2458/8/271
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among these groups was 26,7, 14,2 and 5,5, respectively.
The prevalence of known and newly detected DM by age-
group is shown in table 1. In the age-group 35 to 44 years,
the sex-adjusted odds ratio (OR) for DM was 4.6 [2.0–
10.9] for Hindustani Surinamese and 1.9 [0.8–4.6] for
African Surinamese as compared to the Dutch. In the age
group 45 to 60 years, the OR was 6.1 [3.7–10.3] for Hin-
dustani Surinamese and 2.7 [1.6–4.6] for African Suri-
namese. Hindustani Surinamese and African Surinamese
with DM had a higher odds of being detected, i.e. having
known diabetes, than the Dutch (Hindustani Surinamese
OR: 2.6 [1.1–6.2], African Surinamese OR: 2.7 [1.1–6.7]).
The determinants of DM in the risk score are shown in
Table 2. History of CVD (OR 5.4 [2.9–10.3]) and waist cir-
cumference (OR 5.3 [3.2–8.6]) showed the strongest asso-
ciation with DM in the univariate analysis. In multivariate
analysis, the strongest determinants were history of CVD
(OR 3.0 [1.5–6.3]), a first-degree relative with DM (OR
2.7 [1.8–4.2]) and Hindustani Surinamese origin (OR 2.7
[1.7–4.5]).
Performance of criteria for screening
Table 3 shows the performance of four sets of screening
criteria in the three population subgroups. Selection
Table 1: Characteristics of 35–60 year old Hindustani Surinamese, African Surinamese and ethnic Dutch participants
Hindustani 
Surinamese
(n = 336)
median (IQR) or n (%)
African 
Surinamese
(n = 593)
median (IQR) or n (%)
Ethnic Dutch
(n = 486)
median (IQR) or n (%)
Age (years) 44 (39–50) 43 (39–48) 48 (42–54)
Sex (female) 187 (55.6) 400 (67.5) 242 (49.8)
Level of education (higha) 34 (10.3) 116 (19.8) 175 (36.5)
Level of profession (highb) 98 (32.9) 257 (48.9) 279 (58.3)
Physical activity (at least 30 minutes 5× per weekc) 166 (52.2) 315 (56.2) 306 (63.2)
History of CVD (myocardial infarction and/or stroke) 21 (6.3) 13 (2.2) 10 (2.1)
First degree 
relative with DM
273 (81.3) 371 (62.7) 202 (41.7)
BMI (kg/m2) 26.7 (23.8–29.6) 27.6 (24.5–31.5) 25.4 (22.9–28.3)
(> 25 kg/m2, Hindustani Surinamese: > 23 kg/
m2)
276 (82.1) 420 (71.0) 253 (52.1)
Waist 
circumference
(cm) 94.2 (85.9–101.0) 92.9 (83.1–102.1) 90.3 (81.5–100.3)
(increased waist circumferenced) 261 (77.7) 398 (67.2) 280 (57.6)
Resting heart rate (resting heart rate in bpm) 72.5 (66.5–80.5) 72.0 (65.0–80.0) 68.5 (61.0–76.0)
(resting heart rate ≥ 90 bpm) 29 (8.8) 46 (7.9) 21 (4.4)
Dyslipidemia
HDL-cholesterol (mmol/l) 1.2 (1.0–1.5) 1.4 (1.2–1.7) 1.4 (1.2–1.7)
(< 0.9 mmol/l (35 mg/dl) and/or treated) 63 (18.6) 21 (3.5) 31 (6.4)
Triglyceride (mmol/l) 1.2 (0.9–1.8) 0.8 (0.6–1.2) 1.1 (0.8–1.7)
(> 2.8 mmol/l (250 mg/dl) and/or treated) 51 (15.2) 15 (2.5) 41 (8.4)
Blood pressure
SBP (mmHg) 124.0 (112.0–137.5) 125.0 (114.5–140.5) 121.5 (111.0–134.5)
DBP (mmHg) 81.5 (75.0–89.0) 82.0 (75.5–91.0) 78.5 (71.0–86.0)
Hypertension
(> 140/90 mmHg and/or on anti-hypertensive 
therapy)
115 (35.9) 223 (38.0) 125 (25.7)
Diabetes mellitus (fasting plasma glucose ≥ 7.0 mmol/l and/or 
self-reported)
in 35–44 years known 17 (9.8) 21 (6.1) 5 (3.0)
newly detected 12 (6.9) 7 (2.0) 2 (1.2)
in 45–60 years known 50 (30.7) 38 (15.4) 14 (4.4)
newly detected 7 (4.3) 9 (3.6) 12 (3.8)
Age standardisede known 298 (21.1) 164 (11.6) 46 (3.2)
newly detected 80 (5.7) 37 (2.6) 32 (2.2)
a definition: higher vocational or more (i.e. primary, secondary or lower vocational versus higher vocational or more) b definition: grade of 
employment (as classified by the EGP scheme (routine non-manual employees or higher (high) vs. low) c Dutch physical activity guideline d waist 
circumference > 80 cm for women and > 94 cm for men e Directly standardised to the age distribution of the total population (in 5-year 
categories). Data represent expected number of cases (prevalence). BMI = body mass index, bpm = beats per minute, SBP = systolic blood 
pressure, DBP = diastolic blood pressure, CVD = cardiovascular disease, HDL = high density lipoprotein, DM= diabetes mellitus, IQR = 
interquartile rangeBMC Public Health 2008, 8:271 http://www.biomedcentral.com/1471-2458/8/271
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based on age alone (set 1) showed the lowest diagnostic
accuracy. Application of the risk score (set 4) resulted in a
moderate to good diagnostic accuracy: the AUC was 0.74
(0.70–0.79) for the Hindustani Surinamese, 0.80 (0.75–
0.85) for the African Surinamese, and 0.78 (0.73–0.85)
for the Dutch, with a NNS of 3 among the Hindustani
Surinamese, 5 among the African Surinamese, and 7
among the Dutch. Trends were similar when the analysis
was restricted to persons with normoglycemia and newly
detected DM (Table 4).
In Table 5, we listed the performance of the simplified ver-
sion of the score (as specified in additional file 1: Risk
score for DM SUNSET.pdf), among the population with-
out a prior diagnosis of DM (known DM). The AUC varied
between 0.58 among the Hindustani Surinamese to 0.79
among the African Surinamese. At a cut off of 8 points, 13
Hindustani Surinamese, 22 African Surinamese or 13 eth-
nic Dutch would have to be screened to detect a new case
of DM.
Discussion
To our knowledge, this is the first European study outside
the UK, to report on an evaluation of a risk score as a
screening test for DM across different ethnic groups. The
findings of our study confirm that DM varies strongly
across ethnic groups; Hindustani Surinamese had the
highest prevalence of DM, followed by African Suri-
namese and Dutch. Although the Hindustani Surinamese
population seemed to have a higher proportion of known
DM, the absolute prevalence of newly detected DM was
still higher as compared to the other ethnic groups in both
age categories. These results indicate that Hindustani Suri-
namese in particular, but also the African Surinamese,
could benefit from screening starting before the age of 45
(i.e. the currently advised threshold).
The high prevalence of DM among the Hindustani Suri-
namese and African Surinamese is consistent with studies
among South Asian and Afro-Caribbean populations in
the UK [13-16]. Research in the 1990s suggested that for
every known case there was another undiagnosed case of
DM [4,21,22]. The proportion of newly detected DM in
our study was lower. The proportion among the Dutch in
our sample (nearly one-third) is in agreement with the UK
and the recent data in the USA [23,24]. The proportion of
newly detected DM among the Surinamese was lower. A
higher awareness of the risk of diabetes among Hindus-
tani Surinamese in Dutch clinical practice may contribute
(at least in part) to this low proportion, particularly
among those aged 45 years and older. The relatively low
proportion of newly detected diabetes among African
Surinamese has also been found in Afro-Caribbeans in the
UK [25]. This may be linked to the high prevalence of
hypertension among African origin populations, as clini-
cians may be triggered to test for elevated (fasting) glucose
levels during check-ups for hypertension.
Despite the relatively small proportion of newly detected
DM in Hindustani Surinamese persons, the absolute prev-
alence of newly detected DM is relatively high in Hindus-
tani Surinamese, particularly among those aged 35 to 45
years. This emphasizes the importance and potential ben-
efits of (selective) screening among young people of Hin-
dustani Surinamese origin. More research is needed to
find out whether screening below 35 years of age can be
useful for Hindustani and African Surinamese and other
South Asian and African origin people.
Table 2: Determinants of diabetes mellitus among Hindustani Surinamese, African Surinamese and ethnic Dutch aged 35–60 yearsa
Determinant DM
(n = 194)
Prevalence (%)
no DM
(n = 1221)
Prevalence (%)
Univariate 
OR [95% CI]
Multivariateb 
OR [95% CI]
Age ≥ 45 years 67.0 49.0 2.2 [1.6–3.0] 1.8 [1.2–2.6]
BMI > 25 kg/m2c 89.1 63.6 4.8 [3.0–7.7] 1.9 [1.0–3.4]
Increased waist circumferenced 89.6 62.7 5.3 [3.2–8.6] 2.3 [1.3–4.1]
Resting heart rate ≥ 90 bpm 15.4 5.6 3.1 [1.9–4.9] 2.4 [1.4–4.0]
First-degree relative with DM 82.9 56.2 3.8 [2.5–5.6] 2.7 [1.8–4.2]
Hypertensione 59.0 28.9 3.6 [2.6–4.9] 2.4 [1.7–3.4]
History of CVD 9.8 2.1 5.4 [2.9–10.3] 3.0 [1.5–6.3]
Ethnic group:
Hindustani Surinamese 44.3 20.5 4.8 [3.1–7.4] 2.7 [1.7–4.5]
African Surinamese 38.7 42.4 2.0 [1.3–3.1] 1.5 [0.9–2.4]
Ethnic Dutch 17.0 37.1 1 1
a only determinants selected for the multivariate analysis, based on a Waldtest for univariate association of p < 0.25 are shown b mutually adjusted c 
> 23 kg/m2 for Hindustani Surinamese d waist circumference > 80 cm for all women, > 94 cm for African Surinamese and ethnic Dutch men and > 
90 cm for Hindustani Surinamese men e blood pressure > 140/90 mm Hg and/or being on anti-hypertensive therapy
DM = diabetes mellitus (fasting plasma glucose ≥ 7.0 mmol/l and/or self-reported), OR = odds ratio, CI = confidence interval, BMI = body mass 
index, bpm = beats per minute, CVD = cardiovascular disease (myocardial infarction and/or stroke)BMC Public Health 2008, 8:271 http://www.biomedcentral.com/1471-2458/8/271
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The performance of the new risk score, that was developed
in this study, appears to be at least as accurate or even
more accurate as a screening test for DM than other sets of
screening criteria derived from current guidelines. Com-
pared to the criteria based on age and BMI alone, inclu-
sion of a number of additional parameters significantly
improved the performance for both the South Asian and
African ethnic groups. The parameters included waist cir-
cumference and resting heart rate. In our analyses, we
found that waist circumference appeared to be superior
for predicting the risk of DM when compared to BMI, even
if we used a lower cut-off (BMI ≥ 23) in South Asians as
recommended by the WHO [26]. Moreover, an elevated
heart rate is known to be a risk marker for CVD and asso-
ciated with an increased risk of DM [27,28]. However,
despite a broad range of specific determinants, South
Asian ethnic origin in itself remained one of the most
important predictors.
The advantage of our risk score as compared to the
extended ADA criteria is that it does not require invasive
specimen collection. Previous prospective studies have
also looked at diagnostic criteria based on non-invasive
parameters and shown that the diagnostic accuracy was
potentially good [29-31]. However, only one of these
studies incorporated ethnicity, only 'black' (African Amer-
Table 3: Performance of sets of selective screening criteria for diabetes mellitus among participants in SUNSET
Source AUC (bCI)c Sens (%, CI) Spec (%, CI) Screen (%) Prev (%) NNS
Set criteria for Hindustani Surinamese
1 age ≥ 45 years DCGP 0.62
(0.58–0.67)
66.3
(55.2–75.9)
57.6
(51.2–63.8)
48.5 35.0 3
2 age ≥ 45 and BMI > 25 kg/m2 ADA 0.65
(0.61–0.71)
66.3
(55.2–75.9)
57.6
(51.2–63.8)
48.5 35.0 3
3 criteria 2, and have additional risk factors, as 
followsa
ADA extended 0.74
(0.70–0.79)
79.5
(69.0–87.3)
47.4
(41.0–53.8)
56.4 35.5 3
4 tailored risk scoreb present study 0.74
(0.70–0.79)
75.9
(65,.0–84.3)
54.1
(47.6–60.4)
53.5 35.8 3
Set criteria for African Surinamese
1 age ≥ 45 years DCGP 0.62
(0.58–0.67)
62.7
(50.7–73.3)
61.4
(57.0–65.6)
41.7 19.0 6
2 age ≥ 45 and BMI > 25 kg/m2 ADA 0.68
(0.65–0.75)
59.5
(47.4–70.5)
72.6
(68.5–76.3)
81.1 14.2 8
3 criteria 2, and have additional risk factors, as 
followsa
ADA extended 0.79
(0.76–0.85)
78.1
(66.6–86.6)
60.7
(56.3–65.0)
44.1 22.1 5
4 tailored risk scoreb present study 0.80
(0.75–0.85)
79.2
(67.7–87.5)
62.3
(57.9–66.5)
42.8 23.0 5
Set criteria for ethnic Dutch
1 age ≥ 45 years DCGP 0.57
(0.51–0.63)
78.8
(60.6–90.4)
35.6
(31.2–40.2)
65.4 8.2 13
2 age ≥ 45 and BMI > 25 kg/m2 ADA 0.72
(0.65–0.77)
72.7
(54.2–86.1)
72.7
(60.3–69.3)
79.8 8.0 13
3 criteria 2, and have additional risk factors, as 
followsa
ADA extended 0.79
(0.75–0.87)
71.9
(53.0–85.6)
71.2
(66.7–75.3)
31.7 15.0 7
4 tailored risk scoreb present study 0.78
(0.73–0.85)
77.4
(58.5–89.7)
68.8
(64.2–73.1)
34.3 14.9 7
a physically inactive or 1st-degree relative with DM or high risk ethnic group (Hindustani Surinamese, i.e. South Asian) or hypertensive or reduced 
HDL and/or elevated triglyceride or history of cardiovascular disease.
b optimal screening criteria identified from multivariate analysis (ethnic groups, age, BMI, waist circumference, resting heart rate, first-degree 
relative with DM, hypertension, history of cardiovascular disease)
c bCI: The 'Confidence interval' around the score was estimated via a bootstrapping procedure [20], the 2.5 and 97.5 percentiles are listed between 
brackets. The cut-off value for the SUNSET score was 0.200 for Hindustani Surinamese, 0.077 for African Surinamese and 0.055 for ethnic Dutch. 
DM = diabetes mellitus (fasting plasma glucose ≥ 7.0 mmol/l and/or self-reported), CI = 95%-confidence interval, DCPG = Dutch College of 
General Practitioners, ADA = American Diabetes Association, AUC = area under the curve, a measure of diagnostic accuracy, sens = sensitivity of 
the criteria (value closest to, but not over 80%), spec = specificity corresponding to the listed sensitivity, screen = percentage of the total 
population in this study that is screened, prev = prevalence in the screened population (the predictive value positive), NNS = number needed to 
screen to detect a case of DM in this study, BMI = body mass indexBMC Public Health 2008, 8:271 http://www.biomedcentral.com/1471-2458/8/271
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ican), but did not specifically assess the performance of
the score with only clinical parameters (i.e. non-invasive)
by ethnic group [30]. The two other studies did not
include ethnicity as part of the risk score and were there-
fore not able to design and evaluate the criteria in a multi-
ethnic population.
Before drawing a conclusion, this study has some limita-
tions which should be discussed. First, the performance of
screening criteria in a study population in which the
model is developed, is known to often be too optimistic.
However, the sub-group analyses and the results of the
bootstrapping procedure indicate that our estimate of the
performance of our risk score was valid.
Table 4: Performance of sets of selective screening criteria for the identification of newly detected diabetes mellitus among 
participants in SUNSETc
Source Hindustani Surinamese
N = 269
AUC (bCI)
African Surinamese
N = 534
AUC (bCI)
ethnic Dutch
n = 467
AUC (bCI)
1a g e   ≥ 45 years DCGP 0.53 (0.50–0.61) 0.59 (0.51–0.69) 0.61 (0.54–0.68)
2a g e   ≥ 45 and BMI > 25 kg/m2 ADA 0.61 (0.54–0.70) 0.69 (0.62–0.78) 0.72 (0.65–0.82)
3 criteria 2, and have additional risk factors, as followsa ADA extended 0.69 (0.64–0.83) 0.87 (0.83–0.95) 0.80 (0.74–0.91)
4 tailored risk scoreb present study 0.70 (0.66–0.83) 0.87 (0.83–0.93) 0.78 (0.73–0.90)
a physically inactive or 1st-degree relative with DM or high risk ethnic group (Hindustani Surinamese, i.e. South Asian) or hypertensive or reduced 
high density lipoprotein and/or elevated triglyceride or history of cardiovascular disease.
b optimal screening criteria identified from multivariate analysis (ethnic groups, age, BMI, waist circumference, resting heart rate, first-degree 
relative with DM, hypertension, history of cardiovascular disease)
c Persons with known DM were excluded from the analysis. Data are area under the curve (AUC) and a 'confidence interval' (bCI), based on the 2.5 
and 97.5 percentiles estimated via a bootstrapping procedure [20].
DM = diabetes mellitus (fasting plasma glucose ≥ 7.0 mmol/l and/or self-reported), DCPG = Dutch College of General Practitioners, ADA = 
American Diabetes Association
Table 5: Performance of the simplified risk score for the identification of newly detected diabetes mellitusa
AUC (bCI) Sens (%) Screen (%) Prev (%) NNSnew
Hindustani Surinamese 0.58 (0.49–0.70)
Total population 6.0
≥ 5 points 94.4 97.3 6.6 16
≥ 8 points 94.4 80.7 8.0 13
≥ 11 points 38.9 42.0 6.3 16
African Surinamese 0.79 (0.70–0.89)
Total population 3.1
≥ 5 points 93.8 86.8 3.3 31
≥ 8 points 87.5 58.9 4.5 22
≥ 11 points 81.3 25.8 9.6 11
Ethnic Dutch 0.77 (0.68–0.85)
Total population 3.1
≥ 5 points 100 56.2 5.5 19
≥ 8 points 64.3 24.9 8.0 13
≥ 11 points 14.3 6.4 6.9 15
a Persons with known DM were excluded from the analysis. Simplified score is presented in additional file 1: Risk score for DM SUNSET.pdf. Cut off 
values (number of points) chosen based on the 20–50–75 percentiles in the total population.
DM = diabetes mellitus (fasting plasma glucose ≥ 7.0 mmol/l and/or self-reported), sens = sensitivity of the criteria at the given cut-off, screen = 
percentage of the total population that is screened at the given cut-off, prev = prevalence in the screened population (the predictive value positive), 
NNSnew = number needed to identify a case of newly detected DM, i.e. a previously undiagnosed case of DM in this study, AUC = area under the 
curve, a measure of diagnostic accuracy, bCI = 'confidence interval' estimated via a bootstrapping procedure [20], the 2.5 and 97.5 percentiles are 
listed between brackets.BMC Public Health 2008, 8:271 http://www.biomedcentral.com/1471-2458/8/271
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Second, as in many surveys, the diagnosis of DM was
based on a single fasting plasma glucose, which might
have underestimated the true prevalence rates for DM as
compared to a situation where an oral glucose tolerance
test had been employed [32]. Studies show that over 30%
of persons with DM are missed if the diagnosis is based on
fasting glucose alone, suggesting that the total prevalence
of DM may be higher than reported in our analyses [33-
35].
Moreover, these studies showed that the agreement
between the two methods is dependent on determinants
such as on age and BMI [33,35]. This may affect the valid-
ity of our risk score. The performance of the score for the
identification of persons with DM diagnosed by means of
the oral glucose tolerance test may be insufficient, as our
score was solely based on determinants associated with
DM persons identified by the fasting plasma glucose
measurement. Further studies will have to explore the
validity of the risk score for the identification of DM diag-
nosed by means of the oral glucose tolerance test.
Third, our study is based on cross-sectional self-reported
data. This could have biased the results of behavioural fac-
tors if, as part of treatment, persons with DM changed
their lifestyle. This would imply an underestimation of
how lifestyle-related determinants contribute to DM. In
addition, the cross-sectional nature of the study prevented
us from assessing the risk of incident DM.
Fourth, the participation rate among those invited for the
study was 60%. Although this is reasonable for this type
of study, selective non-response may influence the repre-
sentativeness of the results, i.e. the generalisability to the
original sample. In our study, only small differences were
found in participation in the interview by gender, marital
status, household composition and urbanisation. Unfor-
tunately, no data were available on determinants of DM in
this population. Therefore, we could not determine
whether participants and non-participants were compara-
ble with regard to the determinants and risk of DM. How-
ever, further comparison of participants and non-
participants in the physical examination revealed no dif-
ferences with regard to self-reported DM and self-rated
health between these groups. This suggests that the study
population may be largely representative for the entire
sample.
Conclusion
Management of DM – especially in ethnic groups at high
risk – deserves a great deal of attention in the form of early
detection and prompt treatment. In our study, the preva-
lence of DM was so high among Hindustani Surinamese
and to a lesser extent among African Surinamese that uni-
versal rather than selective screening may be indicated. In
any case, detection and treatment among these ethnic
groups should not just focus on persons 45 years or older,
as is advised in most guidelines, but also include persons
under the age of 45 years. If a choice for selective screening
is made, an ethnicity-specific approach is required. Our
risk score, which includes ethnicity, may be relatively easy
to use in clinical practice. We have shown that it is as accu-
rate as or more accurate than screening criteria derived
from current guidelines. However, we do recommend fur-
ther validation of this new risk score in practice.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
NRB assisted in the design of the SUNSET study, carried
out measurements, participated in the statistical analysis
and drafted the manuscript. IGMV carried out the statisti-
cal analysis, drafted the manuscript and carried out the
revisions. GM, carried out measurements and commented
on the interpretation of the results and the drafts of the
manuscript. RPK conceived and designed the SUNSET
study and commented on the interpretation of the results
and the drafts of the manuscript. FH, JBLH and RPJM con-
tributed to the interpretation of the results and the drafts
of the manuscript. KS conceived and designed the SUN-
SET study, contributed to the statistical analyses and par-
ticipated in the writing and revisions of the manuscript.
All authors read and approved the final version of the
manuscript.
Additional material
Acknowledgements
We are very grateful to Prof. Niek Klazinga for his comments on earlier 
drafts of this manuscript. Furthermore, we are endebted to Dr. Michael 
Tanck, statistician, for his assistance with the analysis, in particular the boot-
strapping procedure.
This study was funded by The Netherlands Organisation for Health 
Research and Development (ZonMw) and the Academic Medical Centre 
(AMC).
References
1. Wild S, Roglic G, Green A, Sicree R, King H: Global Prevalence of
Diabetes, estimates for the year 2000 and projections for
2030.  Diabetes Care 2004, 27:1047-1053.
Additional File 1
'Appendix: The risk score for DM from the population based SUNSET 
cohort'. Instructions on how to calculate the simplified risk score for dia-
betes mellitus from the population based SUNSET cohort.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2458-8-271-S1.pdf]Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Public Health 2008, 8:271 http://www.biomedcentral.com/1471-2458/8/271
Page 10 of 10
(page number not for citation purposes)
2. Diabetes in the UK, october 2004   [http://www.diabetes.org.uk/
Documents/Reports/in_the_UK_2004.doc]
3. DECODE Study Group on behalf of the European Diabetes Epidemi-
ology Study Group: Age- and sex- specific prevalence of diabe-
tes and impaired glucose regulation in 13 European cohorts.
Diabetes Care 2003, 26:61-69.
4. Wareham NJ, Griffin SJ: Should we screen for type 2 diabetes?
Evaluation against National Screening Committee criteria.
BMJ 2001, 322:986-988.
5. Health Council of the Netherlands: Screening for type 2 diabetes (pub-
lication no. 2004/16) The Hague: Health Council of the Netherlands;
2004. 
6. American Diabetes Association: Screening for Diabetes (Posi-
tion Statement).  Diabetes Care 2001, 24:S21-4.
7. Early identification of people with type 2 diabetes   [http://
www.diabetes.org.uk/Documents/Professionals/
Earlyid_TYPE2_PS.doc]
8. Park PJ, Griffin SJ, Sargeant L, Wareham NJ: The performance of a
risk score in predicting undiagnosed hyperglycemia.  Diabetes
Care 2002, 25:984-988.
9. Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ: Diabetes
risk score: towards earlier detection of type 2 diabetes in
general practice.  Diabete Metab Res Rev 2000, 16:164-171.
10. Baan CA, Ruige JB, Stolk RP, Witteman JC, Dekker JM, Heine RJ, Fes-
kens EJ: Performance of a predictive model to identify undiag-
nosed diabetes in a health care setting.  Diabetes Care 1999,
22:213-219.
11. Ruige JB, de Neeling JN, Kostense PJ, Bouter LM, Heine RJ: Perform-
ance of a NIDDM screening questionnaire based on symp-
toms and risk factors.  Diabetes Care 1997, 20:491-496.
12. Herman WH, Smith PJ, Thompson TJ, Engelau MM, Aubert RE: A
new and simple questionnaire to identify people at increased
risk for undiagnosed diabetes.  Diabetes Care 1995, 18:382-387.
13. Mbanya JC, Cruickshank JK, Forrester T, Balkau B, Ngogang JY, Riste
L, Forhan A, Anderson NM, Bennett F, Wilks R: Standardized
comparison of glucose intolerance in west African-origin
populations of rural and urban Cameroon, Jamaica, and Car-
ibbean migrants to Britain.  Diabetes Care 1999, 22:434-440.
14. Bhopal R, Unwin N, White M, Yallop J, Walker L, Alberti KG, Harland
J, Patel S, Ahmad N, Turner C, Watson B, Kaur D, Kulkarni A, Laker
M, Tavridou A: Heterogeneity of coronary heart disease risk
factors in Indian, Pakistani, Bangladeshi, and European ori-
gin populations: cross sectional study.  BMJ 1999, 319:215-220.
15. Cappucio FP, Cook DG, Atkinson RW, Strazullo P: Prevalence,
detection, and management of cardiovascular risk factors in
different ethnic groups in south London.  Heart 1997,
78:555-563.
16. Simmons D, Williams DR, Powell MJ: Prevalence of diabetes in a
predominantly Asian community: preliminary findings of the
Coventry diabetes study.  BMJ 1989, 298(6665):18-21.
17. Spijkerman AMW, Fuyun MF, Griffin SJ, Dekker JM, Nijpels G, Ware-
ham NJ: The Performance of a Risk Score as a Screening Test
for Undiagnosed Hyperglycemia in Ethnic Minority Groups.
Diabetes Care 2004, 27:116-122.
18. American Diabetes Association: Standards of Medical Care in
Diabetes.  Diabetes Care 2005, 28:S4-36.
19. Agyemang CO, Bindraban NR, Mairuhu G, Montfrans G, Koopmans
RP, Stronks K: Prevalence, awareness, treatment, and control
of hypertension among Black Surinamese, South Asian Suri-
namese and White Dutch in Amsterdam, The Netherlands:
the SUNSET study.  J Hypertens 2005, 23:1971-1977.
20. Steyerberg EW, Harrell FE Jr, Borsboom GJ, Eijkemans MJ, Vergouwe
Y, Habbema JD: Internal validation of predictive models: effi-
ciency of some procedures for logistic regression analysis.  J
Clin Epidemiol 2001, 54:774-81.
21. Williams DR, Wareham NJ, Brown DC, Byrne CD, Clark PM, Cox
BD, Cox LJ, Day NE, Hales CN, Palmer CR, Shackleton JR, Wang
TWM: Undiagnosed glucose intolerance in the community:
the Isle of Ely Diabetes Project.  Diabet Med 1995, 12:30-35.
22. Mooy JM, Grootenhuis PA, de Vries H, Valkenburg HA, Bouter LM,
Kostense PJ, Heine RJ: Prevalence and determinants of glucose
intolerance in a Dutch Caucasian population: the Hoorn
study.  Diabetes Care 1990, 18:1270-1273.
23. Forouhi NG, Merrick D, Goyder E, Ferguson BA, Abbas J, Lachowycz
K, Wild SH: Diabetes prevalence in England, 2001–estimates
from an epidemiological model.  Diabetic Medicine 2005,
23:189-197.
24. National Diabetes Factsheet: United States, 2005   [http://
www.cdc.gov/diabetes/pubs/pdf/ndfs_2005.pdf]
25. Cappuccio FP, Cook DG, Atkinson RW, Strazzullo P: Prevalence,
detection, and management of cardiovascular risk factors in
different ethnic groups in south London.  Heart 1997,
78:555-563.
26. The Asia-Pacific Perspective: Redefining Obesity and its
Treatment – Full Report   [http://www.diabetes.com.au/pdf/
obesity_report.pdf]
27. Nilsson PM, Roost M, Egnstrom G, Hedblad B, Berglund G: Inci-
dence of diabetes in Middle-Aged Men is related to Sleep
Disturbances.  Diabetes Care 2004, 27:2464-2469.
28. Palatini P, Casiglia E, Pauletta P, Staessen J, Kaciroti N, Julius S: Rela-
tionship of tachycardia with high blood pressure and meta-
bolic abnormalities: a study with mixture analysis in three
populations.  Hypertension 1997, 30:1267-1273.
29. Lindstrom J, Tuomilehto J: The diabetes risk score: a practical
tool to predict type 2 diabetes risk.  Diabetes Care 2003,
26:725-731.
30. Schmidt MI, Duncan BB, Bang H, Pankow JS, Ballantyne CM, Golden
SH, Folsom AR, Chambless LE: Identifying individuals at high risk
for diabetes: the AtherosclerosisRisk in Communities Study.
Diabetes Care 2005, 28:2013-2018.
31. Schulze MB, Hoffmann K, Boeing H, Linseisen J, Rohrmann S, Möhlig
M, Pfeiffer AF, Spranger J, Thamer C, Häring HU, Fritsche A, Joost
HG: An Accurate Risk Score Based on Anthropometric, Die-
tary, and Lifestyle Factors to Predict the Development of
Type 2 Diabetes.  Diabetes Care 2007, 30:510-515.
32. De Vegt F, Dekker JM, Stehouwer CD, Nijpels G, Bouter LM, Heine
RJ: The 1997 American Diabetes Association criteria versus
1985 World Health Organization criteria for the diagnosis of
abnormal glucose tolerance: poor agreement in the Hoorn
study.  Diabetes Care 1998, 21:1686-1690.
33. No authors listed: Is fasting glucose sufficient to define diabe-
tes? Epidemiological data from 20 European studies. The
DECODE-study group. European Diabetes Epidemiology
Group. Diabetes Epidemiology: Collaborative analysis of
Diagnostic Criteria in Europe.  Diabetologia 1999, 42:647-54.
34. Pomerleau J, McKeigue PM, Chaturvedi N: Relationships of fasting
and postload glucose levels to sex and alcohol consumption.
Are American Diabetes Association criteria biased against
detection of diabetes in women?  Diabetes Care 1999, 22:430-3.
35. Qiao Q, Nakagami T, Tuomilehto J, Borch-Johnsen K, Balkau B,
Iwamoto Y, Tajima N, International Diabetes Epidemiology Group,
DECODA Study Group: Comparison of the fasting and the 2-h
glucose criteria for diabetes in different Asian cohorts.  Dia-
betologia 2000, 43:1470-5.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2458/8/271/pre
pub